---
figid: PMC3319453__nihms-364117-f0002
figtitle: Insulin, IGF-I and IGF-II binding to IR and IGF-IR
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3319453
filename: nihms-364117-f0002.jpg
figlink: /pmc/articles/PMC3319453/figure/F2/
number: F2
caption: 'Insulin, IGF-I and IGF-II binding to IR and IGF-IR. Ligand binding triggers
  receptor autophosphorylation and RTK activation, permitting IRS-1, IRS-2 or Shc
  phosphorylation. Mitogenic signaling pursues via Grb2 activation of the GEF (guanine
  nucleotide exchange factor) SoS, enabling Ras/Rheb activation. Activated Ras/Rheb
  initiates the MAPK/ERK pathway through Raf-1 phosphorylation and enhances mTOR/raptor
  signaling, collectively increasing cell growth, proliferation, protein expression
  and viability. Induction of the PI3K pathway enhances metabolic insulin effects
  and mitigates pro-apoptotic and anti-mitogenic signaling. Hsp90 client proteins
  are indicated with a pink bar and serve crucial roles in regulating insulin/IGF
  signaling. Potential modulation effects of insulin/IGF signaling components upon
  Hsp expression and function are shown in the black box. Abbreviations: BAD, Bcl-2-associated
  death promoter; BAX, Bcl-2-associated X; 4EBP1, eIF4E binding protein-1; CREB, cAMP-response
  element binding; eIF2, eukaryotic initiation factor 2; eIF4E, eukaryotic translation
  initiation factor-4E; ERK-1/2, extracellular-signal-regulated kinase-1/2; FoxO3a,
  forkhead box ‘other’ 3a; GLUT4, glucose transporter 4; Grb2, growth factor receptor-bound
  protein 2; GSK-3β, glycogen synthase kinase-3β; HSF1, heat shock factor-1; Hsp,
  heat shock protein; HSR, heat shock response; IGF-IR, insulin-like growth factor-I
  receptor; IR, insulin receptor; IRS-1/2, insulin receptor substrate-1/2; MAPK, mitogen-activated
  protein kinase; MEK1, MAPK/ERK kinase 1; Met-tRNAiMet, initiator methionyl-tRNA;
  mTOR, mammalian target of rapamycin; raptor, regulatory-associated protein of mTOR;
  MDM2, murine double minute-2; PDK1, phosphoinositide-dependent kinase-1; PI3K, phosphatidylinositol
  3-kinase; PIP2, phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol
  3,4,5-triphosphate; PKC, protein kinase C; PTEN, phosphatase and tensin homolog;
  RTK, receptor tyrosine kinase; Shc, Src homology 2 domain-containing; SoS, son of
  sevenless; TSC, tuberous sclerosis complex.'
papertitle: Heat shock response and insulin-associated neurodegeneration.
reftext: Michael J. Urban, et al. Trends Pharmacol Sci. ;33(3):129-137.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9275671
figid_alias: PMC3319453__F2
figtype: Figure
redirect_from: /figures/PMC3319453__F2
ndex: 2aea49ff-df01-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3319453__nihms-364117-f0002.html
  '@type': Dataset
  description: 'Insulin, IGF-I and IGF-II binding to IR and IGF-IR. Ligand binding
    triggers receptor autophosphorylation and RTK activation, permitting IRS-1, IRS-2
    or Shc phosphorylation. Mitogenic signaling pursues via Grb2 activation of the
    GEF (guanine nucleotide exchange factor) SoS, enabling Ras/Rheb activation. Activated
    Ras/Rheb initiates the MAPK/ERK pathway through Raf-1 phosphorylation and enhances
    mTOR/raptor signaling, collectively increasing cell growth, proliferation, protein
    expression and viability. Induction of the PI3K pathway enhances metabolic insulin
    effects and mitigates pro-apoptotic and anti-mitogenic signaling. Hsp90 client
    proteins are indicated with a pink bar and serve crucial roles in regulating insulin/IGF
    signaling. Potential modulation effects of insulin/IGF signaling components upon
    Hsp expression and function are shown in the black box. Abbreviations: BAD, Bcl-2-associated
    death promoter; BAX, Bcl-2-associated X; 4EBP1, eIF4E binding protein-1; CREB,
    cAMP-response element binding; eIF2, eukaryotic initiation factor 2; eIF4E, eukaryotic
    translation initiation factor-4E; ERK-1/2, extracellular-signal-regulated kinase-1/2;
    FoxO3a, forkhead box ‘other’ 3a; GLUT4, glucose transporter 4; Grb2, growth factor
    receptor-bound protein 2; GSK-3β, glycogen synthase kinase-3β; HSF1, heat shock
    factor-1; Hsp, heat shock protein; HSR, heat shock response; IGF-IR, insulin-like
    growth factor-I receptor; IR, insulin receptor; IRS-1/2, insulin receptor substrate-1/2;
    MAPK, mitogen-activated protein kinase; MEK1, MAPK/ERK kinase 1; Met-tRNAiMet,
    initiator methionyl-tRNA; mTOR, mammalian target of rapamycin; raptor, regulatory-associated
    protein of mTOR; MDM2, murine double minute-2; PDK1, phosphoinositide-dependent
    kinase-1; PI3K, phosphatidylinositol 3-kinase; PIP2, phosphatidylinositol 4,5-bisphosphate;
    PIP3, phosphatidylinositol 3,4,5-triphosphate; PKC, protein kinase C; PTEN, phosphatase
    and tensin homolog; RTK, receptor tyrosine kinase; Shc, Src homology 2 domain-containing;
    SoS, son of sevenless; TSC, tuberous sclerosis complex.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - key
  - Hsp83
  - Gp93
  - Tie
  - Ras85D
  - InR
  - Attenuated
  - path
  - Pdk1
  - Shc
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - drk
  - Sos
  - Pten
  - p53
  - betaTub60D
  - hth
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - ras
  - Ras64B
  - Raf
  - ctp
  - gig
  - Tsc1
  - Akt
  - Mtor
  - Tor
  - raptor
  - rl
  - Thor
  - cass
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - Myc
  - Fas2
  - FASN1
  - Fas3
  - fand
  - tei
  - rg
  - FASN2
  - FASN3
  - S6k
  - kay
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - CycE
  - cyc
  - eIF2alpha
  - eIF2beta
  - eIF2Bepsilon
  - eIF2Bbeta
  - eIF2Balpha
  - Hsf
  - CrebB
  - CrebA
  - tau
  - Hsp27
  - sgg
  - gskt
  - MKP-4
  - p38b
  - Erk7
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - PDK1
  - PDPK1
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - IRS2
  - IRS1
  - PTEN
  - IGF1R
  - TP53
  - TP63
  - TP73
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - KRAS
  - HRAS
  - NRAS
  - RAF1
  - SLC25A1
  - MDM2
  - TSC2
  - TSC1
  - CCL26
  - AKT1
  - AKT2
  - AKT3
  - MAP2K1
  - MTOR
  - MAPK3
  - EIF4EBP1
  - BAD
  - EIF4E
  - EIF4E2
  - EIF4E3
  - MYC
  - FAS
  - FASN
  - RPS6KB1
  - RPS6KB2
  - FOS
  - BAX
  - ELF2
  - EIF2S1
  - EIF2S3
  - EIF2S2
  - EIF2B5
  - EIF2B1
  - EIF2B4
  - EIF2B3
  - EIF2B2
  - HSF1
  - NR5A1
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - MAPT
  - HSPB1
  - HSPB2
  - SLC2A4
  - GSK3B
  - HSR
  - MAPK1
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - Met
  - Cancer
  - Lung cancer
  - Noonan syndrome
---
